Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_provenance.
• NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP108996.RAYpulKo_xJbqGyPJ7pW-TTwaszY0K8LLQqlsSG4exDsw130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108996.RAYpulKo_xJbqGyPJ7pW-TTwaszY0K8LLQqlsSG4exDsw130_provenance.
• NP109011.RAb4axUchGT4xQyCMUe2g-TR0VfsvTBkvEvalKjV8sul0130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109011.RAb4axUchGT4xQyCMUe2g-TR0VfsvTBkvEvalKjV8sul0130_provenance.
• NP109012.RAVLaPBDftWtB3iW4jldOOw4yuGKbtGdSQqMuXhVmQKHk130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109012.RAVLaPBDftWtB3iW4jldOOw4yuGKbtGdSQqMuXhVmQKHk130_provenance.
• NP109194.RAc6sDI20BsEWZq3N4mTOK5u78wFj8ykOeh08NjiQfFKA130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109194.RAc6sDI20BsEWZq3N4mTOK5u78wFj8ykOeh08NjiQfFKA130_provenance.
• NP109196.RAffrUcY5zzGPOFZE4mhCYXNyPn8VOL_VspveEzaxli_M130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109196.RAffrUcY5zzGPOFZE4mhCYXNyPn8VOL_VspveEzaxli_M130_provenance.
• NP119509.RAfyVDw6TXfOU7n0EElauUQ-j0x-JTTMsyogMYiuG6asM130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119509.RAfyVDw6TXfOU7n0EElauUQ-j0x-JTTMsyogMYiuG6asM130_provenance.
• NP119510.RATXCNeRsqUc9rqpWAJmPwijD3b-75LgaEqh32wfjuPgg130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119510.RATXCNeRsqUc9rqpWAJmPwijD3b-75LgaEqh32wfjuPgg130_provenance.
• NP119511.RAXJIYHGRtIQ1T6NRfozw4SeKd5xTyvfpjfOvte848Pq0130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119511.RAXJIYHGRtIQ1T6NRfozw4SeKd5xTyvfpjfOvte848Pq0130_provenance.
• NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119512.RAWFZFYfnT7IR2Uu1mfdTp-Cb2AfS28Oy4qCegHBFYcWs130_provenance.
• NP108995.RAoJQh212pIlz8m7nrPo9_cx3aNUrpOdRMOH1ExaMUHJM130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108995.RAoJQh212pIlz8m7nrPo9_cx3aNUrpOdRMOH1ExaMUHJM130_provenance.
• NP109122.RAlezCF3TXNtWJp03lCFJTfnuKHP0N2632O4eJdbnJG90130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109122.RAlezCF3TXNtWJp03lCFJTfnuKHP0N2632O4eJdbnJG90130_provenance.
• NP109197.RAli2oPvzHYN09XyA_jfCc7q6ld0OEVTfNBf7wRM6m6o4130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109197.RAli2oPvzHYN09XyA_jfCc7q6ld0OEVTfNBf7wRM6m6o4130_provenance.
• NP147182.RAYshrAr6NNBL9M_Y1nIoolDa2VaO8k6REm6ZHXErvEd8130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147182.RAYshrAr6NNBL9M_Y1nIoolDa2VaO8k6REm6ZHXErvEd8130_provenance.
• NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_provenance.
• NP147197.RAbMfXEJLYqh-grFOroRokI6Hw7w1LqKwwfl0xf0lF-Yo130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147197.RAbMfXEJLYqh-grFOroRokI6Hw7w1LqKwwfl0xf0lF-Yo130_provenance.
• NP147200.RAQjlw2tXYIxGmq5pg9DQl3tyfQI7aHoVtHhJ9darKHx8130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147200.RAQjlw2tXYIxGmq5pg9DQl3tyfQI7aHoVtHhJ9darKHx8130_provenance.
• NP147201.RAV9xeGDKsjfDLllM4BLCjtJaJF_hFt9Z0jKhs_FDRvSs130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147201.RAV9xeGDKsjfDLllM4BLCjtJaJF_hFt9Z0jKhs_FDRvSs130_provenance.
• NP119482.RAtE2xX0FT_sAn6UtQ1vFaQmQ9I4ratAeQt64PMYtQ2jw130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119482.RAtE2xX0FT_sAn6UtQ1vFaQmQ9I4ratAeQt64PMYtQ2jw130_provenance.
• NP119483.RAj8_Y5DglNDZQrTqeYMepY8uNH90Fnxern8lwG2Wu0V4130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119483.RAj8_Y5DglNDZQrTqeYMepY8uNH90Fnxern8lwG2Wu0V4130_provenance.
• NP119484.RAlmaUa_pQnaokZhOVT41p7MeD7z_AAK8rLF3xjoJ3aB8130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119484.RAlmaUa_pQnaokZhOVT41p7MeD7z_AAK8rLF3xjoJ3aB8130_provenance.
• NP119485.RAliODRSSLrfj-51s2H3JSjGpfJidaoXxIrKZnzJYsjgI130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119485.RAliODRSSLrfj-51s2H3JSjGpfJidaoXxIrKZnzJYsjgI130_provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP147190.RACmzwcQ0M4_ykLn1y9-0ZCG7rFd0oAEeqfpyBBbduMJo130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147190.RACmzwcQ0M4_ykLn1y9-0ZCG7rFd0oAEeqfpyBBbduMJo130_provenance.
• NP147202.RAADw0C9ZiCB3E4a-i7_8nkm7eAap622kajRTCEAIR1gI130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147202.RAADw0C9ZiCB3E4a-i7_8nkm7eAap622kajRTCEAIR1gI130_provenance.
• NP738126.RADNCXKznOXg1KluNrUw7ZYkXlNaIXamqNsNsOy6SZfdA130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738126.RADNCXKznOXg1KluNrUw7ZYkXlNaIXamqNsNsOy6SZfdA130_provenance.
• NP109014.RACB872GLEIPLI2nXXVR0BfbFq6OhGJXtYdGLgYsAHlb8130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109014.RACB872GLEIPLI2nXXVR0BfbFq6OhGJXtYdGLgYsAHlb8130_provenance.
• NP109124.RABaSPa9OMsr0Tlyf7OH75d_N8F-4Q9oIxuutIb0I3D9o130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109124.RABaSPa9OMsr0Tlyf7OH75d_N8F-4Q9oIxuutIb0I3D9o130_provenance.
• NP738125.RAUnDIbA9pbURthcsnm0_vw65uQbTlGtz_6Qs09VnMbLA130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738125.RAUnDIbA9pbURthcsnm0_vw65uQbTlGtz_6Qs09VnMbLA130_provenance.
• NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_provenance.
• NP147179.RAujSDpxUDpl3RHkYS2KKDxtFZLoYbqV_XllLjGqG7FgI130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147179.RAujSDpxUDpl3RHkYS2KKDxtFZLoYbqV_XllLjGqG7FgI130_provenance.
• NP147185.RAt4rMKkjbisb9v5SjiqckNBJdci4fnl4UUBlk4CWzJiA130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147185.RAt4rMKkjbisb9v5SjiqckNBJdci4fnl4UUBlk4CWzJiA130_provenance.
• NP147187.RApVeodUHxUtAE7dEh11fW5aP7IgVLzDAXuzBK0W2RkfM130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147187.RApVeodUHxUtAE7dEh11fW5aP7IgVLzDAXuzBK0W2RkfM130_provenance.
• NP147191.RAlmN1hJniUqs6jqIiPWt5Imvqx6cmsn3n3-vGt-78ccY130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147191.RAlmN1hJniUqs6jqIiPWt5Imvqx6cmsn3n3-vGt-78ccY130_provenance.
• NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_provenance.
• NP147194.RAn47icNvm9N2iIzcohhWjOkmNsloPZx14sVT1fcdvoNs130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147194.RAn47icNvm9N2iIzcohhWjOkmNsloPZx14sVT1fcdvoNs130_provenance.
• NP147199.RAiCkNXRH2Q62cJoZ_NjJ8GQMFiZVwlp6HsK5gDOCjvmc130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147199.RAiCkNXRH2Q62cJoZ_NjJ8GQMFiZVwlp6HsK5gDOCjvmc130_provenance.
• NP147203.RAsdUQ6ky5JT55Hu44a4UjZgOpoDVi58A3zGrWlposUNw130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147203.RAsdUQ6ky5JT55Hu44a4UjZgOpoDVi58A3zGrWlposUNw130_provenance.
• NP147205.RAjcAHNQ1mjb5WZcvasRPKuT9LbKQusodg0YknnVcP6IA130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147205.RAjcAHNQ1mjb5WZcvasRPKuT9LbKQusodg0YknnVcP6IA130_provenance.
• NP147206.RAssrvYs6Poqp_dYs_cTMuCcT-C_b_78YaiAOhlqJclEQ130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147206.RAssrvYs6Poqp_dYs_cTMuCcT-C_b_78YaiAOhlqJclEQ130_provenance.
• NP147209.RAgCi7prFkPQnu0at6NioTvIHu07RDuVfPFvIU_ONZW20130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147209.RAgCi7prFkPQnu0at6NioTvIHu07RDuVfPFvIU_ONZW20130_provenance.
• NP147211.RApDmatE5ZlogKZabr2FpkOYfKOrld9DUFBeoHlSVKaSI130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147211.RApDmatE5ZlogKZabr2FpkOYfKOrld9DUFBeoHlSVKaSI130_provenance.
• NP108994.RA7p0peWsiAL3batEYFjiF5jQSzQHbq6FxGYer8JJeq1o130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108994.RA7p0peWsiAL3batEYFjiF5jQSzQHbq6FxGYer8JJeq1o130_provenance.
• NP109013.RA1nXu_kF5ehsLRhzPWSx16qTJYvEYRkPGTqF6RpQFUAI130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109013.RA1nXu_kF5ehsLRhzPWSx16qTJYvEYRkPGTqF6RpQFUAI130_provenance.
• NP109120.RA5IqqJ0A92IHxPe0Gpjf3tVp1coZWNVboJSwrFRVjjwY130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109120.RA5IqqJ0A92IHxPe0Gpjf3tVp1coZWNVboJSwrFRVjjwY130_provenance.
• NP109121.RA7gWM8n2xqDROvBdRXICUA5_jP4lxyvrZOFMfMQTZGUA130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109121.RA7gWM8n2xqDROvBdRXICUA5_jP4lxyvrZOFMfMQTZGUA130_provenance.
• NP109195.RA2cRziAamxK7INB4gxxnOCtT_JitZfDWnkC2Oo8dlZWw130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109195.RA2cRziAamxK7INB4gxxnOCtT_JitZfDWnkC2Oo8dlZWw130_provenance.
• NP108997.RAE_aoLA6-Ali8zTsHNnMy3ttHn08succPMeOsnYIZMM8130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108997.RAE_aoLA6-Ali8zTsHNnMy3ttHn08succPMeOsnYIZMM8130_provenance.
• NP109123.RAMpRGeXp7HcCyfDPlETYJc1dv7MEiC2RgHOzNXyMIbmc130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109123.RAMpRGeXp7HcCyfDPlETYJc1dv7MEiC2RgHOzNXyMIbmc130_provenance.
• NP381916.RANFlVFil7fKOraRqbzLvaSmUqsaEhllOXOVruZvTmQ4I130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381916.RANFlVFil7fKOraRqbzLvaSmUqsaEhllOXOVruZvTmQ4I130_provenance.
• NP147183.RAMXUY4_F_kiztOrRxRhb6lF0kK4YKBccXNKT5te0UIo0130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147183.RAMXUY4_F_kiztOrRxRhb6lF0kK4YKBccXNKT5te0UIo0130_provenance.
• NP147184.RAK0E8xTulmP3sLtIThlEaoAYaZC_rYBO-naV01okcmXg130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147184.RAK0E8xTulmP3sLtIThlEaoAYaZC_rYBO-naV01okcmXg130_provenance.
• NP147188.RAHO_LMQjj-YB5W46cfJpXuVns29_bOQOY2qUyTMXimrQ130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147188.RAHO_LMQjj-YB5W46cfJpXuVns29_bOQOY2qUyTMXimrQ130_provenance.
• NP147195.RAMMv102C-vqWy7x4LJerqYCHx5E22djNWMRLt6hN7src130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147195.RAMMv102C-vqWy7x4LJerqYCHx5E22djNWMRLt6hN7src130_provenance.
• NP147180.RA28tWKSgE16tDIitVjozx19T4e2je1beURVUwF6qzemo130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147180.RA28tWKSgE16tDIitVjozx19T4e2je1beURVUwF6qzemo130_provenance.
• NP147181.RA-yWfrjTXXMwZwKtfjKdPWQby3FCK5PZyY5MQpnpHEKQ130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147181.RA-yWfrjTXXMwZwKtfjKdPWQby3FCK5PZyY5MQpnpHEKQ130_provenance.
• NP147186.RA-9IGxS2QwlntKbklNL7peVDyN5RNKFdNGhY7GDYiyk8130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147186.RA-9IGxS2QwlntKbklNL7peVDyN5RNKFdNGhY7GDYiyk8130_provenance.
• NP147196.RAxd7dPduQzDQgAjldDWP795OkqhzLL5PwswH8sZQHMSY130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147196.RAxd7dPduQzDQgAjldDWP795OkqhzLL5PwswH8sZQHMSY130_provenance.
• NP147198.RA8SU4PgOwUVEr3PoDkeEG5GZQTfdJ8J6b8J74BzY4uPg130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147198.RA8SU4PgOwUVEr3PoDkeEG5GZQTfdJ8J6b8J74BzY4uPg130_provenance.
• NP147204.RA6aMBaM8MeW4gAHk28Srd3fizZ6v0Nd75xVxrPatXwGI130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147204.RA6aMBaM8MeW4gAHk28Srd3fizZ6v0Nd75xVxrPatXwGI130_provenance.
• NP147208.RA2_lIh5aB-U81V-f0CExpEZd6cLNn-yapkukvvoSNRwE130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147208.RA2_lIh5aB-U81V-f0CExpEZd6cLNn-yapkukvvoSNRwE130_provenance.
• NP147213.RA4uPZcMQabecDhtK8PfL5dev-_ZUWXQ0k69x01-c-mQU130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147213.RA4uPZcMQabecDhtK8PfL5dev-_ZUWXQ0k69x01-c-mQU130_provenance.